SHANNON SOZZI: Open Payments
NPI 1538578232 · GREENVILLE, SC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$269 in 15 payments from 9 companies in 2025. Trend: 2023 $429 · 2024 $505 · 2025 $269
Food & beverage: $269
| Company | Payments | Amount |
|---|---|---|
| Otsuka America Pharmaceutical, Inc. | 4 | $78 |
| Alkermes, Inc. | 3 | $61 |
| Janssen Pharmaceuticals, Inc | 2 | $32 |
| Teva Pharmaceuticals USA, Inc. | 1 | $19 |
| ABBVIE INC. | 1 | $18 |
| Noven Therapeutics, LLC | 1 | $18 |
| Vanda Pharmaceuticals Inc. | 1 | $15 |
| Axsome Therapeutics, Inc. | 1 | $15 |
| Neurocrine BioSciences, Inc. | 1 | $14 |
Products named: ARISTADA, ABILIFY ASIMTUFII, INVEGA SUSTENNA, ABILIFY MAINTENA, UZEDY, VRAYLAR, Xelstrym, HETLIOZ.
Industry payments across SC — which companies pay providers there.
